These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39029302)

  • 1. Association of early dexmedetomidine exposure with brain injury biomarker levels following moderate - Severe traumatic brain injury: A TRACK-TBI study.
    Wongsripuemtet P; Ohnuma T; Temkin N; Barber J; Komisarow J; Manley GT; Hatfield J; Treggiari M; Colton K; Sasannejad C; Chaikittisilpa N; Ivins-O'Keefe K; Grandhi R; Laskowitz D; Mathew JP; Hernandez A; James ML; Raghunathan K; Miller J; Vavilala M; Krishnamoorthy V;
    J Clin Neurosci; 2024 Aug; 126():338-347. PubMed ID: 39029302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Early Dexmedetomidine Utilization With Clinical Outcomes After Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort Study.
    Liu SY; Kelly-Hedrick M; Komisarow J; Hatfield J; Ohnuma T; Treggiari MM; Colton K; Arulraja E; Vavilala MS; Laskowitz DT; Mathew JP; Hernandez A; James ML; Raghunathan K; Krishnamoorthy V
    Anesth Analg; 2024 Aug; 139(2):366-374. PubMed ID: 38335145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
    Puccio AM; Yue JK; Korley FK; Okonkwo DO; Diaz-Arrastia R; Yuh EL; Ferguson AR; Mukherjee P; Wang KKW; Taylor SR; Deng H; Markowitz AJ; Sun X; Jain S; Manley GT
    J Neurotrauma; 2024 Jun; 41(11-12):1353-1363. PubMed ID: 38251868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Early Dexmedetomidine Utilization With Clinical and Functional Outcomes Following Moderate-Severe Traumatic Brain Injury: A Transforming Clinical Research and Knowledge in Traumatic Brain Injury Study.
    Liu SY; Kelly-Hedrick M; Temkin N; Barber J; Komisarow J; Hatfield J; Ohnuma T; Manley G; Treggiari MM; Colton K; Vavilala MS; Grandhi R; Laskowitz DT; Mathew JP; Hernandez A; James ML; Raghunathan K; Goldstein B; Markowitz A; Krishnamoorthy V;
    Crit Care Med; 2024 Apr; 52(4):607-617. PubMed ID: 37966330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Brain Injury Biomarkers and Circulatory Shock Following Moderate-Severe Traumatic Brain Injury: A TRACK-TBI Study.
    Toro C; Jain S; Sun S; Temkin N; Barber J; Manley G; Komisarow JM; Ohnuma T; Foreman B; Korley F; James ML; Laskowitz D; Vavilala MS; Hernandez A; Mathew JP; Markowitz AJ; Krishnamoorthy V;
    J Neurosurg Anesthesiol; 2023 Jul; 35(3):284-291. PubMed ID: 34967764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
    Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
    Okonkwo DO; Puffer RC; Puccio AM; Yuh EL; Yue JK; Diaz-Arrastia R; Korley FK; Wang KKW; Sun X; Taylor SR; Mukherjee P; Markowitz AJ; Jain S; Manley GT;
    J Neurotrauma; 2020 Dec; 37(23):2460-2467. PubMed ID: 32854584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
    Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
    Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Performance of S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein, and Ubiquitin C-Terminal Hydrolase L1 for Intracranial Injury Within Six Hours of Injury and Beyond.
    Trivedi D; Forssten MP; Cao Y; Ismail AM; Czeiter E; Amrein K; Kobeissy F; Wang KKW; DeSoucy E; Buki A; Mohseni S
    J Neurotrauma; 2024 Feb; 41(3-4):349-358. PubMed ID: 38115670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
    J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
    Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
    J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.
    Korley F; Pauls Q; Yeatts SD; Jones CMC; Corbett-Valade E; Silbergleit R; Frankel M; Barsan W; Cahill ND; Bazarian JJ; Wright DW
    J Neurotrauma; 2021 Jul; 38(14):1953-1960. PubMed ID: 33319651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions.
    Biberthaler P; Musaelyan K; Krieg S; Meyer B; Stimmer H; Zapf J; von Matthey F; Chandran R; Marino JA; Beligere G; Hoffmann M; Zhang H; Datwyler SA; McQuiston B
    Neurotrauma Rep; 2021; 2(1):617-625. PubMed ID: 35018363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study.
    Åkerlund CAI; Holst A; Bhattacharyay S; Stocchetti N; Steyerberg E; Smielewski P; Menon DK; Ercole A; Nelson DW;
    Lancet Neurol; 2024 Jan; 23(1):71-80. PubMed ID: 37977157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum biomarkers identify critically ill traumatic brain injury patients for MRI.
    Richter S; Winzeck S; Czeiter E; Amrein K; Kornaropoulos EN; Verheyden J; Sugar G; Yang Z; Wang K; Maas AIR; Steyerberg E; Büki A; Newcombe VFJ; Menon DK;
    Crit Care; 2022 Nov; 26(1):369. PubMed ID: 36447266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes-an analysis of CENTER-TBI data.
    Robba C; Graziano F; Picetti E; Åkerlund C; Addis A; Pastore G; Sivero M; Rebora P; Galimberti S; Stocchetti N; Maas A; Menon DK; Citerio G;
    Intensive Care Med; 2024 Mar; 50(3):371-384. PubMed ID: 38376517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
    Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.